Chorionic villus sampling (CVS) is a newer and slightly more risky alternative to amniocentesis that is performed earlier in the course of development, between 10 and 12 weeks of pregnancy.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at the annual Society for Maternal-Fetal Medicine ...